Related references
Note: Only part of the references are listed.Current treatment and future directions in the management of anal cancer
Leila T. Tchelebi et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2022)
Long-Term Outcomes of NRG Oncology/RTOG 0529: A Phase 2 Evaluation of Dose-Painted Intensity Modulated Radiation Therapy in Combination With 5-Fluorouracil and Mitomycin-C for the Reduction of Acute Morbidity in Anal Canal Cancer
Lisa A. Kachnic et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2022)
Cancer Statistics, 2021
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
Outcomes following local excision of early anal squamous cell carcinomas of the anal canal and perianal margin
Tom A. Maccabe et al.
COLORECTAL DISEASE (2021)
Evolution of the Role of Radiotherapy for Anal Cancer
Edward Christopher Dee et al.
CANCERS (2021)
Anal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
S. Rao et al.
ANNALS OF ONCOLOGY (2021)
Squamous rectal carcinoma: a rare malignancy, literature review and management recommendations
C. Astaras et al.
ESMO OPEN (2021)
The 2019 WHO classification of tumours of the digestive system
Iris D. Nagtegaal et al.
HISTOPATHOLOGY (2020)
The prognostic role of FDG PET/CT before combined radio-chemotherapy in anal cancer patients
Lucia Leccisotti et al.
ANNALS OF NUCLEAR MEDICINE (2020)
Recent Trends in Squamous Cell Carcinoma of the Anus Incidence and Mortality in the United States, 2001-2015
Ashish A. Deshmukh et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2020)
Survival Outcomes After Initial Treatment for Anal Adenocarcinoma: A Population-Based Cohort Study
Hyojung Park
CLINICAL COLORECTAL CANCER (2020)
Factors Impacting Differential Outcomes in the Definitive Radiation Treatment of Anal Cancer Between HIV-Positive and HIV-Negative Patients
Matthew Susko et al.
ONCOLOGIST (2020)
Impact of compliance to chemoradiation on long-term outcomes in squamous cell carcinoma of the anus: results of a post hoc analysis from the randomised phase III ACT II trial
R. Glynne-Jones et al.
ANNALS OF ONCOLOGY (2020)
International Rare Cancers Initiative Multicenter Randomized Phase II Trial of Cisplatin and Fluorouracil Versus Carboplatin and Paclitaxel in Advanced Anal Cancer: InterAAct
Sheela Rao et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
POD1UM-202: Phase II study of retifanlimab in patients (pts) with squamous carcinoma of the anal canal (SCAC) who progressed following platinum-based chemotherapy
S. Rao et al.
ANNALS OF ONCOLOGY (2020)
Final results of the CARACAS study: Randomized phase II trial of avelumab alone or with cetuximab for unresectable, locally advanced or metastatic squamous cell anal carcinoma progressed to at least one line of treatment
S. Lonardi et al.
ANNALS OF ONCOLOGY (2020)
Outcomes with anti-EGFR monoclonal antibodies in metastatic and recurrent anal squamous cell carcinoma
Jane E. Rogers et al.
EXPERT REVIEW OF ANTICANCER THERAPY (2020)
Association of tumour mutational burden with outcomes in patients with advanced solid tumours treated with pembrolizumab: prospective biomarker analysis of the multicohort, open-label, phase 2 KEYNOTE-158 study
Aurelien Marabelle et al.
LANCET ONCOLOGY (2020)
Bintrafusp alfa, a bifunctional fusion protein targeting TGF-β and PD-L1, in patients with human papillomavirus-associated malignancies
Julius Strauss et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2020)
FOLFCIS Treatment and Genomic Correlates of Response in Advanced Anal Squamous Cell Cancer
Sebastian Mondaca et al.
CLINICAL COLORECTAL CANCER (2019)
Incidence and time trends of anal cancer among people living with HIV in Australia
Fengyi Jin et al.
AIDS (2019)
Anal cancer chemoradiotherapy outcome prediction using 18F-fluorodeoxyglucose positron emission tomography and clinicopathological factors
Espen Rusten et al.
BRITISH JOURNAL OF RADIOLOGY (2019)
Prognostic value of fluorodeoxyglucose positron emission tomography/computed tomography and inguinal sentinel lymph node biopsy in patients with anal cancer
P. De Nardi et al.
COLORECTAL DISEASE (2019)
Pencil Beam Scanning Proton Beam Chemoradiation Therapy With 5-Fluorouracil and Mitomycin-C for Definitive Treatment of Carcinoma of the Anal Canal: A Multi-institutional Pilot Feasibility Study
Jennifer Y. Wo et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2019)
A Phase II Study of Capecitabine/Oxaliplatin With Concurrent Radiotherapy in Locally Advanced Squamous Cell Carcinoma of the Anal Canal
Cathy Eng et al.
CLINICAL COLORECTAL CANCER (2019)
Prognostic utility of pre- and post-treatment FDG-PET parameters in anal squamous cell carcinoma
Adele Duimering et al.
RADIOTHERAPY AND ONCOLOGY (2019)
Impact of Surgical Resection on Survival Outcomes After Chemoradiotherapy in Anal Adenocarcinoma
Richard Li et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2019)
Clinical Validity of HPV Circulating Tumor DNA in Advanced Anal Carcinoma: An Ancillary Study to the Epitopes-HPV02 Trial
Alice Bernard-Tessier et al.
CLINICAL CANCER RESEARCH (2019)
Comparison of definitive chemoradiation with 5-fluorouracil versus capecitabine in anal cancer
Yoanna Pumpalova et al.
JOURNAL OF GASTROINTESTINAL ONCOLOGY (2019)
Prognostic and Predictive Clinicopathologic Factors of Squamous Anal Canal Cancer in HIV-Positive and HIV-Negative Patients: Does HAART Influence Outcomes?
Emmanouil P. Pappou et al.
WORLD JOURNAL OF SURGERY (2018)
Salvage Abdominoperineal Resection for Squamous Cell Anal Cancer: A 30-Year Single-Institution Experience
J. A. W. Hagemans et al.
ANNALS OF SURGICAL ONCOLOGY (2018)
Anal Cancer Risk Among People With HIV Infection in the United States
Vivian Colon-Lopez et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Docetaxel, cisplatin, and fluorouracil chemotherapy for metastatic or unresectable locally recurrent anal squamous cell carcinoma (Epitopes-HPV02): a multicentre, single-arm, phase 2 study
Stefano Kim et al.
LANCET ONCOLOGY (2018)
Landscape of Tumor Mutation Load, Mismatch RepairDeficiency, and PD-L1 Expression in a Large Patient Cohort of Gastrointestinal Cancers
Mohamed E. Salem et al.
MOLECULAR CANCER RESEARCH (2018)
Prognostic Significance of Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography in Anal Squamous Cell Carcinoma: A Systematic Review and a Meta-Analysis
Ramin Sadeghi et al.
CONTRAST MEDIA & MOLECULAR IMAGING (2018)
Prognostic Impact of Residual HPV ctDNA Detection after Chemoradiotherapy for Anal Squamous Cell Carcinoma
Luc Cabel et al.
CLINICAL CANCER RESEARCH (2018)
Hematologic Nadirs During Chemoradiation for Anal Cancer: Temporal Characterization and Dosimetric Predictors
Andrew Y. Lee et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2017)
Capecitabine With Mitomycin Reduces Acute Hematologic Toxicity and Treatment Delays in Patients Undergoing Definitive Chemoradiation Using Intensity Modulated Radiation Therapy for Anal Cancer
Karyn A. Goodman et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2017)
Cetuximab Plus Chemoradiotherapy in Immunocompetent Patients With Anal Carcinoma: A Phase II Eastern Cooperative Oncology Group-American College of Radiology Imaging Network Cancer Research Group Trial (E3205)
Madhur K. Garg et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Cetuximab Plus Chemoradiotherapy for HIV-Associated Anal Carcinoma: A Phase II AIDS Malignancy Consortium Trial
Joseph A. Sparano et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Best time to assess complete clinical response after chemoradiotherapy in squamous cell carcinoma of the anus (ACT II): a post-hoc analysis of randomised controlled phase 3 trial
Robert Glynne-Jones et al.
LANCET ONCOLOGY (2017)
Nivolumab for previously treated unresectable metastatic anal cancer (NCI9673): a multicentre, single-arm, phase 2 study
Van K. Morris et al.
LANCET ONCOLOGY (2017)
Comprehensive Genomic Profiling of Metastatic Squamous Cell Carcinoma of the Anal Canal
Van Morris et al.
MOLECULAR CANCER RESEARCH (2017)
Integrated genomic and molecular characterization of cervical cancer
Robert D. Burk et al.
NATURE (2017)
Patient Perspective and Personal Journey of Treating a Rare Cancer
Michele Longabaugh
SURGICAL ONCOLOGY CLINICS OF NORTH AMERICA (2017)
Pathology of Anal Cancer
Paulo M. Hoff et al.
SURGICAL ONCOLOGY CLINICS OF NORTH AMERICA (2017)
Human Immunodeficiency Virus/AIDS, Human Papillomavirus, and Anal Cancer
Chia-ching J. Wang et al.
SURGICAL ONCOLOGY CLINICS OF NORTH AMERICA (2017)
Diagnostic performance of magnetic resonance imaging and 3D endoanal ultrasound in detection, staging and assessment post treatment, in anal cancer
Alfonso Reginelli et al.
ONCOTARGET (2017)
Liver transplant recipients have a higher prevalence of anal squamous intraepithelial lesions
A. Albuquerque et al.
BRITISH JOURNAL OF CANCER (2017)
Anal cancer: French Intergroup Clinical Practice Guidelines for diagnosis, treatment and follow-up (SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO, SNFCP)
Laurence Moureau-Zabotto et al.
DIGESTIVE AND LIVER DISEASE (2017)
Association of Coloproctology of Great Britain & Ireland (ACPGBI): Guidelines for the Management of Cancer of the Colon, Rectum and Anus (2017) - Anal Cancer
Ian Geh et al.
COLORECTAL DISEASE (2017)
Safety and antitumor activity of the anti-PD-1 antibody pembrolizumab in patients with recurrent carcinoma of the anal canal
P. A. Ott et al.
ANNALS OF ONCOLOGY (2017)
Predictors of acute toxicities during definitive chemoradiation using intensity-modulated radiotherapy for anal squamous cell carcinoma
Diana A. R. Julie et al.
ACTA ONCOLOGICA (2016)
Anal cancer FDG-PET standard uptake value: correlation with tumor characteristics, treatment response and survival
Letizia Deantonio et al.
RADIOLOGIA MEDICA (2016)
Comprehensive genomic profiling of anal squamous cell carcinoma reveals distinct genomically defined classes
J. H. Chung et al.
ANNALS OF ONCOLOGY (2016)
Evidence-based indications for the use of PET-CT in the United Kingdom 2016
The Royal College of Radiologists et al.
CLINICAL RADIOLOGY (2016)
Pencil-beam scanning proton therapy for anal cancer: a dosimetric comparison with intensity-modulated radiotherapy
Eric Ojerholm et al.
ACTA ONCOLOGICA (2015)
Anal Cancer Incidence in the United States, 1977-2011: Distinct Patterns by Histology and Behavior
Meredith S. Shiels et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2015)
Late effects and quality of life after chemo-radiation for the treatment of anal cancer
Gillian Knowles et al.
EUROPEAN JOURNAL OF ONCOLOGY NURSING (2015)
Comprehensive genomic characterization of head and neck squamous cell carcinomas
Michael S. Lawrence et al.
NATURE (2015)
Prospective study of vaginal dilator use adherence and efficacy following radiotherapy
Ethel Law et al.
RADIOTHERAPY AND ONCOLOGY (2015)
Prospective Evaluation of Acute Toxicity and Quality of Life After IMRT and Concurrent Chemotherapy for Anal Canal and Perianal Cancer
Kathy Han et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2014)
Anal cancer: ESMO-ESSO-ESTRO clinical practice guidelines for diagnosis, treatment and follow-up
Robert Glynne-Jones et al.
RADIOTHERAPY AND ONCOLOGY (2014)
The role of systemic chemotherapy and multidisciplinary management in improving the overall survival of patients with metastatic squamous cell carcinoma of the anal canal
Cathy Eng et al.
ONCOTARGET (2014)
Impaired health-related quality of life after chemoradiotherapy for anal cancer: Late effects in a national cohort of 128 survivors
Anne Gry Bentzen et al.
ACTA ONCOLOGICA (2013)
Long-Term Results of Weekly/Daily Cisplatin-Based Chemoradiation for Locally Advanced Squamous Cell Carcinoma of the Anal Canal
Cathy Eng et al.
CANCER (2013)
Anal Carcinoma: Impact of TN Category of Disease on Survival, Disease Relapse, and Colostomy Failure in US Gastrointestinal Intergroup RTOG 98-11 Phase 3 Trial
Leonard L. Gunderson et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2013)
RTOG 0529: A Phase 2 Evaluation of Dose-Painted Intensity Modulated Radiation Therapy in Combination With 5-Fluorouracil and Mitomycin-C for the Reduction of Acute Morbidity in Carcinoma of the Anal Canal
Lisa A. Kachnic et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2013)
Mitomycin or cisplatin chemoradiation with or without maintenance chemotherapy for treatment of squamous-cell carcinoma of the anus (ACT II): a randomised, phase 3, open-label, 2x2 factorial trial
Roger D. James et al.
LANCET ONCOLOGY (2013)
The treatment of squamous anal carcinoma: guidelines of the Italian society of colo-rectal surgery
I. Giani et al.
TECHNIQUES IN COLOPROCTOLOGY (2013)
Cancer in the Transplant Recipient
Jeremy R. Chapman et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2013)
The Lower Anogenital Squamous Terminology Standardization Project for HPV-Associated Lesions: Background and Consensus Recommendations from the College of American Pathologists and the American Society for Colposcopy and Cervical Pathology
Teresa M. Darragh et al.
ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE (2012)
Risk of Anal Cancer in HIV-Infected and HIV-Uninfected Individuals in North America
Michael J. Silverberg et al.
CLINICAL INFECTIOUS DISEASES (2012)
Practice Parameters for Anal Squamous Neoplasms
Scott R. Steele et al.
DISEASES OF THE COLON & RECTUM (2012)
Normal Tissue Complication Probability Modeling of Acute Hematologic Toxicity in Patients Treated With Intensity-Modulated Radiation Therapy for Squamous Cell Carcinoma of the Anal Canal
Jose G. Bazan et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2012)
Role of Positron Emission Tomography-Computed Tomography in the Management of Anal Cancer
Massimiliano Mistrangelo et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2012)
Australasian Gastrointestinal Trials Group (AGITG) Contouring Atlas and Planning Guidelines for Intensity-Modulated Radiotherapy in Anal Cancer
Michael Ng et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2012)
DOSE-PAINTED INTENSITY-MODULATED RADIATION THERAPY FOR ANAL CANCER: A MULTI-INSTITUTIONAL REPORT OF ACUTE TOXICITY AND RESPONSE TO THERAPY
Lisa A. Kachnic et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2012)
Long-Term Update of US GI Intergroup RTOG 98-11 Phase III Trial for Anal Carcinoma: Survival, Relapse, and Colostomy Failure With Concurrent Chemoradiation Involving Fluorouracil/Mitomycin Versus Fluorouracil/Cisplatin
Leonard L. Gunderson et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Induction Chemotherapy and Dose Intensification of the Radiation Boost in Locally Advanced Anal Canal Carcinoma: Final Analysis of the Randomized UNICANCER ACCORD 03 Trial
Didier Peiffert et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Reproducibility and genital sparing with a vaginal dilator used for female anal cancer patients
Tina Marie Briere et al.
RADIOTHERAPY AND ONCOLOGY (2012)
F-18-FDG PET/CT Imaging In Oncology
Ahmad Almuhaideb et al.
ANNALS OF SAUDI MEDICINE (2011)
Anal Cancer and Cervical Cancer Screening: Key Differences
Teresa M. Darragh et al.
CANCER CYTOPATHOLOGY (2011)
Anal cancers among HIV-infected persons: HAART is not slowing rising incidence
Nancy F. Crum-Cianflone et al.
AIDS (2010)
Effects of KRAS, BRAF, NRAS, and PIK3CA mutations on the efficacy of cetuximab plus chemotherapy in chemotherapy-refractory metastatic colorectal cancer: a retrospective consortium analysis
Wendy De Roock et al.
LANCET ONCOLOGY (2010)
Anal cancer maximum F-18 fluorodeoxyglucose uptake on positron emission tomography is correlated with prognosis
Elizabeth A. Kidd et al.
RADIOTHERAPY AND ONCOLOGY (2010)
The impact of 18-fluorodeoxyglucose positron emission tomography on the staging, management and outcome of anal cancer
E. de Winton et al.
BRITISH JOURNAL OF CANCER (2009)
A Twenty-Year Experience with Adenocarcinoma of the Anal Canal
George J. Chang et al.
DISEASES OF THE COLON & RECTUM (2009)
ELECTIVE CLINICAL TARGET VOLUMES FOR CONFORMAL THERAPY IN ANORECTAL CANCER: A RADIATION THERAPY ONCOLOGY GROUP CONSENSUS PANEL CONTOURING ATLAS
Robert J. Myerson et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2009)
Involved-field, low-dose chemoradiotherapy for early-stage anal carcinoma
Paul Hatfield et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2008)
Extra - A multicenter phase II study of chemoradiation using a 5 day per week oral regimen of capecitabine and intravenous mitomycin C in anal cancer
Rob Glynne-Jones et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2008)
Fluorouracil, mitomycin, and radiotherapy vs fluorouracil, cisplatin, and radiotherapy for carcinoma of the anal canal - A randomized controlled trial
Jaffer A. Ajani et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2008)
Induction therapy for poor-prognosis anal canal carcinoma: A phase II study of the cancer and leukemia group B (CALGB 9281)
Neal J. Meropol et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Role of human papillomavirus in squamous cell metaplasia-dysplasia-carcinoma of the rectum
Christina S. Kong et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2007)
Anal cancer in renal transplant patients
Heena S. Patel et al.
INTERNATIONAL JOURNAL OF COLORECTAL DISEASE (2007)
FDG-PET/CT in the evaluation of anal carcinoma
Shane E. Cotter et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2006)
Anal canal carcinoma:: early-stage tumors ≤10 mm (T1 or Tis):: Therapeutic options and original pattern of local failure after radiotherapy
C Ortholan et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2005)
Effective treatment of anal cancer in the elderly with low-dose chemoradiotherapy
N Charnley et al.
BRITISH JOURNAL OF CANCER (2005)
Human papillomavirus type 16-positive cervical cancer is associated with impaired CD4+T-cell immunity against early antigens E2 and E6
A de Jong et al.
CANCER RESEARCH (2004)
Recapitulation of the effects of the human papillomavirus type 16 E7 oncogene on mouse epithelium by somatic Rb deletion and detection of pRb-independent effects of E7 in vivo
SJ Balsitis et al.
MOLECULAR AND CELLULAR BIOLOGY (2003)
Does human papilloma virus have a role in squamous cell carcinoma of the colon and upper rectum?
A Audeau et al.
EUROPEAN JOURNAL OF SURGICAL ONCOLOGY (2002)
Share Paper
